dementia (FTD). We test whether apathy develops in presymptomatic genetic FTD, and is
associated with cognitive decline and brain atrophy. Methods Presymptomatic carriers of
MAPT, GRN or C9orf72 mutations (N= 304), and relatives without mutations (N= 296)
underwent clinical assessments and MRI at baseline, and annually for 2 years. Longitudinal
changes in apathy, cognition, gray matter volumes, and their relationships were analyzed …